Payment overview · 2025
General Payments
$21.32
1 reported records · 1 companies
Healthcare provider profile · identity verified
Michael J Knapp, DO
Allopathic & Osteopathic Physicians|Family Medicine · ABERDEEN, SD · NPI 1215905518
Verified facts
What the public records show
CMS Open Payments records show Michael J Knapp, DO received $21.32 in general payments during 2025 across 1 reported records.
Medtronic, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$21.32 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $21.32 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MINIMED 780G Normalized: minimed 780g |
Device | Medtronic, Inc. | $21.32 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 532 | 119 |
| Amlodipine Besylate | Amlodipine Besylate | 422 | 100 |
| Omeprazole | Omeprazole | 422 | 104 |
| Atorvastatin Calcium | Atorvastatin Calcium | 370 | 105 |
| Lisinopril | Lisinopril | 360 | 93 |
| Furosemide | Furosemide | 308 | 65 |
| Simvastatin | Simvastatin | 300 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 299 | 68 |
| Metformin Hcl | Metformin Hcl | 281 | 71 |
| Losartan Potassium | Losartan Potassium | 280 | 63 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 263 | 69 |
| Potassium Chloride | Potassium Chloride | 200 | 36 |
| Metoprolol Tartrate | Metoprolol Tartrate | 194 | 46 |
| Hydrochlorothiazide | Hydrochlorothiazide | 177 | 48 |
| Sertraline Hcl | Sertraline Hcl | 177 | 33 |
| Eliquis | Apixaban | 176 | 25 |
| Warfarin Sodium | Warfarin Sodium | 167 | 18 |
| Tamsulosin Hcl | Tamsulosin Hcl | 144 | 32 |
| Gabapentin | Gabapentin | 140 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 131 | 31 |
| Carvedilol | Carvedilol | 114 | 25 |
| Glipizide | Glipizide | 112 | 38 |
| Trazodone Hcl | Trazodone Hcl | 109 | 23 |
| Duloxetine Hcl | Duloxetine Hcl | 106 | 18 |
| Allopurinol | Allopurinol | 103 | 26 |
| Lovastatin | Lovastatin | 103 | 26 |
| Tramadol Hcl | Tramadol Hcl | 101 | 25 |
| Jantoven | Warfarin Sodium | 99 | 15 |
| Memantine Hcl | Memantine Hcl | 90 | 16 |
| Famotidine | Famotidine | 89 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 88 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 86 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 84 | 19 |
| Prednisone | Prednisone | 84 | 57 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 83 | 83 |
| Alprazolam | Alprazolam | 80 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 79 | 20 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 77 | 21 |
| Alendronate Sodium | Alendronate Sodium | 74 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 72 | suppressed |
| Meloxicam | Meloxicam | 71 | 17 |
| Valsartan | Valsartan | 70 | 18 |
| Montelukast Sodium | Montelukast Sodium | 69 | 13 |
| Ozempic | Semaglutide | 69 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 69 | 16 |
| Doxazosin Mesylate | Doxazosin Mesylate | 66 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 64 | 15 |
| Naproxen | Naproxen | 61 | 29 |
| Donepezil Hcl | Donepezil Hcl | 58 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 57 | 12 |
| Fluticasone Propionate | Fluticasone Propionate | 56 | 19 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 56 | 41 |
| Pravastatin Sodium | Pravastatin Sodium | 55 | 17 |
| Levetiracetam | Levetiracetam | 53 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 52 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 52 | suppressed |
| Mirtazapine | Mirtazapine | 52 | suppressed |
| Digoxin | Digoxin | 51 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 50 | suppressed |
| Lorazepam | Lorazepam | 49 | 17 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 49 | suppressed |
| Baclofen | Baclofen | 48 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 45 | 14 |
| Pioglitazone Hcl | Pioglitazone Hcl | 41 | suppressed |
| Sucralfate | Sucralfate | 40 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 39 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 37 | 17 |
| Spironolactone | Spironolactone | 37 | 11 |
| Finasteride | Finasteride | 36 | suppressed |
| Jardiance | Empagliflozin | 36 | suppressed |
| Pregabalin | Pregabalin | 35 | suppressed |
| Atenolol | Atenolol | 34 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 33 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 32 | suppressed |
| Xarelto | Rivaroxaban | 32 | suppressed |
| Lamotrigine | Lamotrigine | 31 | suppressed |
| Metolazone | Metolazone | 31 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 28 |
| Bumetanide | Bumetanide | 29 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 29 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 28 | suppressed |
| Glipizide Er | Glipizide | 28 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 28 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 27 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 27 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 26 | suppressed |
| Latanoprost | Latanoprost | 26 | suppressed |
| Sodium Chloride | Sodium Chloride Irrig Solution | 26 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 24 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 25 | 25 |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 25 | suppressed |
| Cephalexin | Cephalexin | 25 | 18 |
| Glimepiride | Glimepiride | 24 | suppressed |
| Lacosamide | Lacosamide | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 24 | suppressed |
| Risperidone | Risperidone | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Ibuprofen | Ibuprofen | 23 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 23 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 22 |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Cilostazol | Cilostazol | 22 | suppressed |
| Clonazepam | Clonazepam | 22 | suppressed |
| Januvia | Sitagliptin Phosphate | 21 | suppressed |
| Loperamide | Loperamide Hcl | 21 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 21 | suppressed |
| Aripiprazole | Aripiprazole | 20 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 20 | suppressed |
| Fenofibrate | Fenofibrate | 20 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 20 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 20 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 20 | 14 |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | 12 |
| Raloxifene Hcl | Raloxifene Hcl | 19 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 18 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 18 | suppressed |
| Diazepam | Diazepam | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Amoxicillin | Amoxicillin | 17 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 17 | 11 |
| Dutasteride | Dutasteride | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 15 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 15 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 15 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 14 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Niacin Er | Niacin | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 14 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 13 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 13 | suppressed |
| Nystop | Nystatin | 13 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 13 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Celecoxib | Celecoxib | 12 | suppressed |
| Folic Acid | Folic Acid | 12 | suppressed |
| Gemfibrozil | Gemfibrozil | 12 | suppressed |
| Letrozole | Letrozole | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 11 | suppressed |
| Methylphenidate Er (La) | Methylphenidate Hcl | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 11 | suppressed |
| Nyamyc | Nystatin | 11 | suppressed |
| Risperidone Odt | Risperidone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $21.32 · 1 records | Medtronic, Inc. | MINIMED 780G | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error